Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New diabetes pill taken every two weeks shows promise in study

NCT ID NCT07198932

First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 28 times

Summary

This study looks at two diabetes medications, cofrogliptin and linagliptin, when added to insulin treatment in Chinese adults with type 2 diabetes. The goal is to see which one works better at controlling blood sugar and is safer. About 594 participants will be followed in real-world clinics, not a lab.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Affiliated Hospital of Hebei University

    Baoding, China

  • Beijing Luhe Hospital Affiliated to Capital Medical University

    Beijing, China

  • Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University

    Shanghai, China

  • Shanghai Changzheng Hospital

    Shanghai, China

  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

    Hangzhou, Zhejiang, China

  • Xi'an International Medical Center Hospital

    Xi'an, China

  • the First Medical Center of Chinese PLA General Hospital

    Beijing, China

Conditions

Explore the condition pages connected to this study.